News Center

News Center

Home page

Blog Center

News Center

Viwit Pharmaceuticals' Sterile Production Facility Successfully Passes U.S. FDA Inspection

Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA

Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA

Viwit's Nitroglycerin Sublingual Tablets Approved by FDA

Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"

Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.

Welcome participants in CPhI Worldwide 2017, booth 80M63

Author：

Release Time：

2017-10-24

CPhI Worldwide 2017 will be held from October 24th to 26th, 2017 at the Frankfurt Expo Center in Germany. Welcome to patronage of Viwit, booth number: 80M63. If you would like to make an appointment in advance, please email us at service@viwit.com.

Previous

The exhibition of Viwit pharmaceutical CPhI India 2017 has come to a successful conclusion

VIA Pharma 2017 CPhI Worldwide Exhibition Successfully Ends

Next

VIWIT

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search